alexa Pediatric thrombocytopenia | Sweden | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Journals

Relevant Topics

Pediatric Thrombocytopenia

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Pediatric thrombocytopenia

    Pathophysiology

    Pediatric Thrombocytopenia is a condition in which you have a low blood platelet count. Platelets (thrombocytes) are colorless blood cells that help blood clot. Platelets stop bleeding by clumping and forming plugs in blood vessel injuries. Thrombocytopenia often occurs as a result of a separate disorder, such as leukemia or an immune system problem. Or it can be a side effect of taking certain medications. It affects both children and adults. Thrombocytopenia may be mild and cause few signs or symptoms. In rare cases, the number of platelets may be so low that dangerous internal bleeding occurs. Treatment options are available.

  • Pediatric thrombocytopenia

    Disease statistics

    In Sweden the total approximately estimated population is 8,986,400 out of this population 25,587 are extarpolated or suffering from this disease or diagnosed

  • Pediatric thrombocytopenia

    Treatment

    Specific treatments for thrombocytopenia will be determined by your child’s physicians based on the cause and severity of the disease, as well as your child’s tolerance for medications, procedures and therapies. Mild cases may not require treatment and may resolve on their own. Blood transfusions with platelets or red blood cells are sometimes needed.

  • Pediatric thrombocytopenia

    Research

    We do clinical treatment studies, most recently centering around rituximab and the thrombopoietic agents as well as studies also exploring the mechanism of Pediatric thrombocytopenia and various markers connected with it. For example, we have looked at the role of different infectious agents (CMV, H Pylori, HIV) in causing ITP, and we have looked at the effects of thrombopoietic agents on the bone marrow and are attempting to relate responses to platelet antibody types. We collaborate with Paul Basciano on studies of a polymorphism in the H1 domain of beta tubulin for which preliminary data suggests a major role in response to several treatments.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings